2023 |
DatChat Inc
|
Independent Director |
73.3 K |
22.2 % |
2023 |
Hoth Therapeutics Inc
|
Independent Director |
65.2 K |
9.9 % |
2023 |
SILO Pharma Inc
|
Independent Director |
45 K |
-25.1 % |
2022 |
SILO Pharma Inc
|
Independent Director |
60.1 K |
100.4 % |
2022 |
DatChat Inc - Warrants - Series A (13/08/2024)
|
Independent Director |
60 K |
- |
2022 |
DatChat Inc
|
- |
60 K |
-82.4 % |
2022 |
Hoth Therapeutics Inc
|
Independent Director |
59.3 K |
-31.8 % |
2021 |
DatChat Inc
|
Independent Director |
341.6 K |
- |
2021 |
Hoth Therapeutics Inc
|
Independent Director |
87.0 K |
9.0 % |
2021 |
SILO Pharma Inc
|
Independent Director |
30 K |
- |
2020 |
Hoth Therapeutics Inc
|
Independent Director |
79.9 K |
- |
2020 |
DatChat Inc
|
Independent Director |
- |
- |
2019 |
Hoth Therapeutics Inc
|
Independent Director |
- |
- |